Alfred Douba

Alfred Douba

Auto-generated profile, based on publicly available information

Alfred Douba

Public Health Department, Felix Houphouet-Boigny University, Abidjan, Cote d’Ivoire; Epidemiological Surveillance Department, National Institute of Public Hygiene, Abidjan, Cote d’Ivoire

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMargaret McCarron
Margaret McCarron
TYTat Sang Yau
Tat Sang Yau
CGChelsey Griffin
Chelsey Griffin
PMPerrine Marcenac
Perrine Marcenac
MEMalembe S Ebama
Malembe S Ebama
JBJoseph Bresee
Joseph Bresee
Vaccination is the most effective way to prevent influenza infection and adverse outcomes; despite global recommendations to vaccinate pregnant persons, access to influenza vaccines remains low. We explored knowledge, attitudes, and practices of pregnant persons to inform actions to improve vaccine uptake. We pooled data from cross-sectional surveys assessing pregnant persons’ attitudes toward influenza vaccines in 8 low- and middle-income countries. Countries used standard methods to measure attitudes and intents toward influenza vaccination. We stratified by presence/absence of a national influenza vaccination program, income group, geographic region, and individual-level factors. Our analysis included 8556 pregnant persons from 8 countries. Most pregnant persons (6323, 74%) were willing to receive influenza vaccine if it was offered for free. Willingness differed by presence of an existing influenza vaccination program; acceptance was higher in countries without programs (2383, 89%) than in those with programs (3940, 67%, P < .001). Most pregnant persons in middle-income countries, regardless of influenza vaccination program status, were willing to be vaccinated against influenza if the vaccine was provided free of charge. National investments in influenza vaccination programs present an opportunity to avert illness both in pregnant persons themselves and in their newborn babies.

5 December 2017 in Santé Publique
Verified
Journal Article
Closed access
PDF file
ABAssemien Boa
Assemien Boa
ADAlfred Douba
Alfred Douba
TNTah Bi N’guessan
Tah Bi N’guessan
HMHervé Menan
Hervé Menan
AAAlain Attia
Alain Attia
RDRaphaël Kalet Dally
Raphaël Kalet Dally
Le Comité National d’Experts Indépendants pour la Vaccination et les Vaccins de Côte d’Ivoire (CNEIV-CI) a inscrit dans son plan de travail de l’année 2015 l’élaboration d’un avis sur l’introduction, à la naissance, d’une dose de vaccin contre l’hépatite virale B dans le calendrier vaccinal du Programme Elargi de Vaccination (PEV). La réalisation de cette tâche a nécessité la mise en place d’un groupe de travail et l’application d’une méthode systématisée. Le groupe a exploité les publications scientifiques portant sur le poids épidémiologique de l’hépatite B en Côte d’Ivoire, le poids de la transmission mère-enfant de l’hépatite B, l’impact de la vaccination à la naissance dans les pays qui ont adopté cette stratégie vaccinale, l’efficacité et l’innocuité du vaccin chez le nouveau-né, le coût-bénéfice de la vaccination à la naissance et la stratégie la plus optimale actuellement en cas d’introduction d’une dose vaccinale à la naissance dans le calendrier vaccinal du PEV. A l’issue de ce travail, le CNEIV-CI a recommandé l’introduction à la naissance d’une dose de vaccin monovalent contre l’hépatite B dans le PEV de routine avec le maintien des trois doses du vaccin pentavalent (DTC-HépB-Hib) à six, 10 et 14 semaines.

13 November 2024 in Central African Journal of Public Health
Verified
Journal Article
Open access
PDF file
ADAlfred Douba
Alfred Douba
NANicaise Bernadin Lepri Aka
Nicaise Bernadin Lepri Aka
EAEric Martial Kouakou Ahoussou
Eric Martial Kouakou Ahoussou
BABangaman Christian AKANI
Bangaman Christian AKANI
MAMarie Noelle Ano
Marie Noelle Ano
TITiembre Issaka
Tiembre Issaka
Background. In 2022, the WHO recommended the vaccination of breastfeeding women against COVID-19. In the same year, the Minister of Health sent a referral to the National Committee of Independent Experts for Vaccination and Vaccines of Côte d'Ivoire (CNEIV-CI) for its opinion on the vaccination of breastfeeding women against COVID-19 in the country. The CNEIV-CI recommended the vaccination of breastfeeding women against COVID-19. Objective. To identify factors associated with COVID-19 vaccination among breastfeeding women. Method. We conducted a cross-sectional survey. The study population consisted of breastfeeding women. Data were collected, using a questionnaire, in health centers during a direct interview with breastfeeding women who came for their child's vaccination. The dependent variables were COVID-19 vaccination status and vaccination intention after weaning, and the independent variables were age, education level, religion, living with a partner, and district of residence. A multivariate analysis, by logistic regression, was performed to search for factors associated with COVID-19 vaccination status, on the one hand, and with vaccination intention after weaning, on the other hand. The measure of association was the adjusted Odds Ratio (ajOR) with a 95% confidence interval (95% CI) and a degree of significance p < 0.05. The data were analyzed using SPSS. Results. A total of 1009 breastfeeding women were surveyed. The respondents median age was 29 years; the minimum age was 16 years and the maximum age was 44 years. 49 % of respondents were vaccinated. Factors associated with COVID-19 vaccination status among breastfeeding women were education level (ajOR = 8.57; 95 % CI: 4.92 – 14.94), living with a partner (ajOR = 4.75; 95 % CI: 3.34 – 6.76), and age group (ajOR = 1.63; 95 % CI: 1.02 – 2.6). Conclusion. Awareness-raising among women on the acceptance of COVID-19 vaccination must continue. Factors associated with COVID-19 vaccination status were living with a partner, education level, and age group. Qualitative studies could be carried out to understand the underlying reasons behind non-vaccination among breastfeeding women.

26 September 2024 in Central African Journal of Public Health
Verified
Journal Article
Open access
PDF file
ADAlfred Douba
Alfred Douba
NANicaise Bernadin Lepri Aka
Nicaise Bernadin Lepri Aka
BABangaman Christian AKANI
Bangaman Christian AKANI
EAEric Martial Kouakou Ahoussou
Eric Martial Kouakou Ahoussou
ABAssemien Boa
Assemien Boa
TITiembre Issaka
Tiembre Issaka
Background. Coronavirus 2019 or COVID-19 is an emerging respiratory disease caused by a new human coronavirus first detected in December 2019, in Wuhan, China. Beliefs and perceptions play an important role in the adoption of health behaviors. Objective. The objective of this study is to identify factors associated with belief in vaccine protection against COVID-19 in Côte d'Ivoire. Method. We carried out a cross-sectional survey for analytical purposes. We conducted a two-stage cluster survey. The first stage involved selecting 40 clusters in each district, by systematic random sampling. The second stage consisted in selecting the households. In each household, the person surveyed was the head of household. In his absence, the head of household's representative was interviewed. The dependent variable was the belief in COVID-19 vaccine protection. Factors associated with the dependent variable were identified using logistic regression. The measure of association was the Adjusted Odds Ratio (ajOR) with a 95% confidence interval (95% CI). Data were analyzed using PASW Statistics 18. Result. A total of 3,611 people were surveyed including 53% of females, 87 of individuals aged 18 to 59 years, 48% of Christian, 47% of Muslim, and 49% of vaccinated individuals. Factors associated with belief in COVID-19 vaccine protection were cohabitation (ajOR 1.71 [1.27 – 2.31]), religion (ajOR 0.58 [0.43 – 0.79]) and age (ajOR [ajOR 0.37 [0.16 – 0.86]). Conclusion. Socio-demographic factors associated with belief in vaccine protection against COVID-19 in our study were marital status, religion, and age. Health authorities should take into account these factors in developing strategies to increase COVID-19 vaccine acceptance. Qualitative studies could be carried out to understand the underlying reasons behind the belief in vaccine protection against COVID-19 or the reasons for COVID-19 vaccination hesitancy or refusal.

8 September 2025 in Central African Journal of Public Health
Verified
Journal Article
Open access
PDF file
ANAno Ama Kounangui Marie Noëlle
Ano Ama Kounangui Marie Noëlle
EDEkra Kouadio Daniel
Ekra Kouadio Daniel
BABangaman Christian AKANI
Bangaman Christian AKANI
MFMakonga Makonga Franck
Makonga Makonga Franck
KSKrouma Sita
Krouma Sita
ITIssaka Tiembré
Issaka Tiembré
Context: The COVID-19 pandemic has highlighted critical weaknesses in global health systems, underscoring the need to strengthen emergency preparedness capacities. Abidjan, the rapidly growing capital of Côte d'Ivoire, faces unprecedented threats to health and livelihoods due to deadly annual floods and the resulting waterborne diseases such as cholera, dengue fever, and leptospirosis. It must be noted that, to date, the health districts of Abidjan, although basic units of the health system, do not have a regional PHEOC, which raises concerns about their level of preparedness. The National PHEOC, under the supervision of the National Institute of Public Health (NIPH), coordinates preparedness and response to health emergencies. It develops contingency plans and improves its capabilities through simulation exercises. The health districts (HDs) of Abidjan, grouped into two health regions: Abidjan 1 Grands Ponts and Abidjan 2 Lagunes, are not members of the national PHEOC. This observation raises concerns about the capacity of this operational unit to respond quickly to health emergencies in its area of intervention. Consequently, questions arise: how is the coordination and planning of interventions in the event of public health emergencies structured within this specific regional hub that is Abidjan? How prepared are Abidjan's health districts to respond to health risks in the city? Objective: To assess organizational capacities for health emergency preparedness in the two health regions of Abidjan (Côte d’Ivoire) in 2024. Methods: A descriptive cross-sectional study conducted from May 1 to June 8, 2024, among 31 key stakeholders in the ten health districts of Abidjan. A structured questionnaire, based on the 2021 WHO preparedness framework, was administered. Data were entered into SPSS and analyzed. Results: The median age of participants was 47 years, and the male-to-female ratio was 1.4. Sixty-eight percent were general practitioners or pharmacists, and 61% had a specialization in public health. Seventy-seven percent of districts had a Rapid Response Team (RRT), and 13% had conducted simulation exercises. However, 68% reported a lack of funds dedicated to emergencies, and 35% reported a lack of effective alert and awareness mechanisms. Conclusion: This study highlights the crucial importance of preparedness and management of health emergencies in Côte d'Ivoire, particularly in the city of Abidjan. In the health regions of Abidjan, organizational capacities for health emergency preparedness remain insufficient despite increasing vulnerability to epidemics. Consolidate surveillance and alert systems to improve the resilience of the health system.